Cancer immunotherapy pill could be on the horizon
Israeli and Portuguese researchers develop tiny synthetic molecules that can penetrate less accessible areas of tumors and could be taken orally.
Israel 21C 11.08.2022
A recent breakthrough by Israeli and Portuguese scientists could result in cancer immunotherapy in a pill form that wouldn’t require a hospital stay or intravenous injection, would be less expensive and may offer other benefits as well.
Image - Eric Sultan/University of Lisbon
Did you find this article interesting?